Rothschild & Co Asset Management US’s Pediatrix Medical MD Stock Holding History

Rothschild & Co Asset Management US’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,005	Closed	-$597K	–	557
2016 Q3	$597K	Sell	9,005 -13,428	-60%	-$918K	0.01%	403
2016 Q2	$1.63M	Sell	22,433 -158,889	-88%	-$10.9M	0.03%	330
2016 Q1	$11.7M	Buy	181,322 +4,083	+2%	+$271K	0.22%	160
2015 Q4	$12.7M	Sell	177,239 -26,855	-13%	-$1.99M	0.23%	146
2015 Q3	$15.7M	Sell	204,094 -6,696	-3%	-$540K	0.31%	111
2015 Q2	$15.6M	Buy	210,790 +2,715	+1%	+$195K	0.29%	118
2015 Q1	$15.1M	Buy	208,075 +42,697	+26%	+$2.97M	0.29%	118
2014 Q4	$10.9M	Sell	165,378 -8,477	-5%	-$517K	0.22%	141
2014 Q3	$9.53M	Sell	173,855 -6,638	-4%	-$377K	0.2%	156
2014 Q2	$10.5M	Buy	180,493 +34,094	+23%	+$2.01M	0.22%	150
2014 Q1	$9.07M	Buy	+146,399	New	+$8.52M	0.2%	179

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Rothschild & Co Asset Management US's MD Position: Q4 2016 in Review

Rothschild & Co Asset Management US sold out of Pediatrix Medical (MD) in Q4 2016, closing a stake of 9,005 shares — an estimated $597K sold.

Rothschild & Co Asset Management US first reported a position in MD in Q1 2014 and held it in 11 quarters. The position peaked at $15.7M in Q3 2015. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

Rothschild & Co Asset Management US reported no remaining Pediatrix Medical position as of Q4 2016 after selling out during the quarter.
Rothschild & Co Asset Management US sold 9,005 Pediatrix Medical shares in Q4 2016, an estimated $597K.
Rothschild & Co Asset Management US first reported a position in Pediatrix Medical in Q1 2014 and held it in 11 quarters.
Rothschild & Co Asset Management US's Pediatrix Medical position peaked at $15.7M in Q3 2015.
383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2016, filed 15 Feb 2017.